General Western Blot Reagents
Abcam Human Histone H3 (tri methyl K36) peptide, 1MG
Human Histone H3 (tri methyl K36) peptide is a Synthetic blocking peptide. >90% purity and suitable for BL, Dot.
Protein/ Peptide/ Enzyme Synonyms: H3FA, HIST1H3A, H3C2, H3FL, HIST1H3B, H3C3, H3FC HIST1H3C, H3C4, H3FB, HIST1H3D, H3C6, H3FD, HIST1H3E, H3C7, H3FI, HIST1H3F, H3C8, H3FH, HIST1H3G, H3C10, H3FK, HIST1H3H, H3C11, H3FF, HIST1H3I, H3C12, H3FJ, HIST1H3J, HIST1H3C, H3FC, H3C1, Histone H3.1, Histone H3/a, Histone H3/b, Histone H3/c, Histone H3/d, Histone H3/f, Histone H3/h, Histone H3/i, Histone H3/j, Histone H3/k, Histone H3/l, H3K36me3
Conjugation: Unconjugated
The product is subject to the following: Abcam Restricted Use Statement
Abcam Thymol, phenolic disinfectant, 25G
MW 150.22 g/mol, Purity >98%. Phenolic compound, originally obtained from thyme oil, that is used to inhibit oral bacteria. Also used as a cosmetic biocide/preservative and/or fragrance ingredient. Functions as a denaturant and fragrance ingredient in cosmetic formulations.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Acetosyringone, phenolic compound, 1G
MW 196.2 g/mol, Purity >98%. Naturally occurring phenolic compound found in plants and used in plant-pathogen recognition. Effective inducer of the virulence genes of Agrobacterium tumefaciens. Used in the synthesis of tetramethoxychalcone and its analogues as anticancer agents invitro.
The product is subject to the following: Abcam Restricted Use Statement
Abcam MUG, Fluorescent beta-glucuronidase substrate, 250MG
MW 388.33 g/mol, Purity >99%. Fluorescent substrate for β-glucuronidase. Once cleaved, yields a blue fluorescent end product that can be monitored by UV light. Typically used in the β-glucuronidase (GUS) reporter system, for fluorescent detection of β-glucuronidase gene expression in Escherichia coli and transformed plants.
The product is subject to the following: Abcam Restricted Use Statement
Abcam MU-GLU, Fluorogenic beta-glucosidase substrate, 100MG
MW 338.32 g/mol. Fluorogenic substrate of β-glucosidase and β-glucocerebrosidase (also known as glucosylceramidase). Used for characterizing novel β-glucosidases. Also used in assays to evaluate deficiency in β-glucocerebrosidase activity related to Gaucher disease. Hydrolysis releases the fluorescent product 4-MU. Fluorescence: λex 365 nm; λem 445 nm in 0.1 M sodium acetate pH 5.0 (after cleavage by β-glucosidase).
The product is subject to the following: Abcam Restricted Use Statement
Abcam Caged MK 801, NMDA receptor open-channel blocker, 50MG
MW 460.49 g/mol, Purity >99%. Caged, potent, selective, non-competitive, irreversible NMDA receptor open-channel blocker. UV-active MK 801 (ab144485, ab120027, ab120028) analog. Shows anticonvulsant effects in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam STAT3 Transcription Factor Assay Kit (Colorimetric).
STAT3 Transcription Factor Assay Kit (Colorimetric).
The product is subject to the following: Abcam Restricted Use Statement
Abcam Human NRG1 type III peptide, 1MG
Human NRG1 type III peptide is a Synthetic blocking peptide. Suitable for BL.
Protein/ Peptide/ Enzyme Synonyms: GGF, HGL, HRGA, NDF, SMDF, NRG1, Pro-NRG1
Conjugation: Unconjugated
The product is subject to the following: Abcam Restricted Use Statement
Abcam AICAR (Acadesine/AICA riboside) (mM/ml), AMP-activated protein kinase activator, 50MM_ML
MW 258.23 Da, Purity >98%. Cell-permeable activator of AMP-activated protein kinase. Is taken up into cells by adenosine transporters and phosphorylated by adenosine kinase to the active nucleotide ZMP (5-aminoimidazole-4-carboxamide ribonucleoside), which mimics effects of AMP on the AMPK system. Active in vivo and in vitro.
The product is subject to the following: Abcam Restricted Use Statement
Abcam (S)-3,4-DCPG (UBP1109) (mM/ml), mGlu8a agonist, 50MM_ML
MW 239.18 Da, Purity >99%. Potent, selective mGlu8a agonist (EC50 = 31 nM). Displays >100-fold selectivity over mGlu1-7. Systemically active in vivo. Soluble in 1 ml water to give specified mM/ml concentration.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Ibotenic acid (mM/ml), e x citoto x ic agonist, 10MM_ML
MW 158.11 Da, Purity >98%. Neuroexcitatory amino acid originally isolated from Amanita species. Neurotoxin often used to model cognitive dysfunctions. NMDA and metabotropic receptor agonist.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Ro 25-6981 maleate salt (mM/ml), NR2B antagonist, 20MM_ML
MW 455.5 Da, Purity >98%. Potent, highly selective, activity-dependent blocker of NMDA receptors that contain the NR2B subunit (IC₅₀ values are 0.009 and 52 μM at NR1C/NR2B and NR1C/NR2A, respectively). Displays no significant activity at kainate/AMPA receptors, Na+ and Ca²+ channels at concentrations showing maximal protection in neurotoxicity tests. Neuroprotective actions in vivo and in vitro.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Ionomycin (free acid) (ethanol solution), Ca2+ ionophore, 5MG
MW 709 Da, Purity >97%. Potent, highly selective Ca2+ ionophore. Effective mobile ion carrier for Ca2+, highly specific for divalent cations (Ca > Mg >> Sr = Ba). Useful for studies of Ca2+ transport across biological membranes and increasing intracellular Ca2+ concentrations. Complexes with Ca2+ between pH 7 and 9.5. Absorption max. (280 nm, MeOH): 18600 M-1cm-1.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Diltiazem (mM/ml), L-type Ca2+ channel antagonist, 100MM_ML
MW 451 Da, Purity >99%. L-type Ca2+ channel antagonist. Coronary vasodilator. Soluble in 1 ml water to give specified mM/ml concentration.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Verapamil hydrochloride (mM/ml), L-type Ca2+ channel blocker, 50MM_ML
MW 491.1 Da, Purity >99%. L-type Ca2+ channel blocker. Antiarrhythmic in vivo. Soluble in 1 ml water to give specified mM/ml concentration.
The product is subject to the following: Abcam Restricted Use Statement